The discovery of MYSM1 mutations in patients with a hereditary developmental and bone marrow failure syndrome raises strong interest in understanding the MYSM1-regulated checkpoints in mammalian physiology and the underlying molecular mechanisms of MYSM1 activity in these systems. Here, MYSM1 is linked to bone marrow failure syndrome.